MKI67 and neoplasm: In contrast to hormone-receptor positive breast tumors, TNBCs display aggressive tumor behavior, high proliferation (Ki67), higher risk of relapse and metastatic disease, shorter overall survival, and sensitivity to chemotherapy [1–6].